BioRestorative Therapies (BRTX) vs Alaunos Therapeutics (TCRT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
BioRestorative Therapies is the larger company by market cap ($2.6 million vs $2.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BRTX | TCRT |
|---|---|---|
| Share price | $1.89 | $0.781 |
| Market cap | $2.61M | $2.29M |
| 1-day change | -15.63% | -6.70% |
| EPS (TTM) | $-21.40 | $-1.76 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $34.40 | $4.50 |
| 52-week low | $1.75 | $0.72 |
| Distance from 52-week high | -94.51% | -82.64% |
| Analyst consensus | buy | — |
| Avg. price target upside | +15773.02% | — |
| Average volume | 26.05K | 797.20K |
| Shares outstanding | 1.38M | 2.93M |
| Employees | 13 | 1 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About BioRestorative Therapies
BRTX stock →BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
Healthcare · Biotechnology · 13 employees
About Alaunos Therapeutics
TCRT stock →Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs.
Healthcare · Biotechnology · 1 employees
BRTX vs TCRT FAQ
Which is bigger, BioRestorative Therapies or Alaunos Therapeutics?
BioRestorative Therapies (BRTX) is larger, with a market capitalization of $2.61M compared with $2.29M for Alaunos Therapeutics (TCRT).
Are BioRestorative Therapies and Alaunos Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.